The regulatory distinction you made is so crucial: the July FDA advisory committee meeting on BPC-157, TB-500, KPV, and others is about compounding access through the 503A pathway, not approval, and not evidence of efficacy
Controlled-release language should be used carefully and only when supported by formulation-specific data
Studies using the chicken chorioallantoic membrane (CAM) assay and various rodent wound models have shown enhanced blood vessel formation in BPC-157-treated groups
But even after this first step, the development of cosmetic peptides progressed at a slow pace
Aer separation of DNA and RNA, the latter was further puried using the RNeasy Mini kit (Qiagen) following the suppliers instructions
Add 3.0 mL bacteriostatic water to one 5 mg vial ~1.67 mg/mL (1,667 mcg/mL), a practical dilution for accurate dosing